Concepedia

Luca Gambini

LG

Statistics

Publications

17

Citations

765

H-Index

16

Active since

2014

Affiliations

University of California, Riverside(Current)

University of Milan

Sanford Burnham Prebys Medical Discovery Institute

University of California San Diego

Cedars-Sinai Medical Center

Luca Gambini is an author at University of California, Riverside specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2014–2022

17

Publications

17

Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues

Luca Gambini, Carlo Baggio, Parima Udompholkul et al. · Journal of Medicinal Chemistry · 2019 · 136 citations · Full text

Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction

Jessica Jang, Jiang Li, Luca Gambini et al. · Proceedings of the National Academy of Sciences · 2017 · 95 citations · Full text

Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate

Ahmed F. Salem, Si Wang, Sandrine Billet et al. · Journal of Medicinal Chemistry · 2018 · 65 citations · Full text

NMR Fingerprints of the Drug‐like Natural‐Product Space Identify Iotrochotazine A: A Chemical Probe to Study Parkinson’s Disease

Tanja Grkovic, Rebecca H. Pouwer, Marie‐Laure Vial et al. · Angewandte Chemie International Edition · 2014 · 63 citations · Full text

Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy

Carlo Baggio, Parima Udompholkul, Luca Gambini et al. · Journal of Medicinal Chemistry · 2019 · 60 citations · Full text

, , +19

1–5 of 17